DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T‐Cell Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T‐Cell Acute Lymphoblastic Leukemia

Published:2016-02-29 Issue:7 Volume:63 Page:1185-1192
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Borssén Magnus¹,Haider Zahra¹,Landfors Mattias¹,Norén‐Nyström Ulrika²,Schmiegelow Kjeld³,Åsberg Ann E.⁴,Kanerva Jukka⁵,Madsen Hans O.⁶,Marquart Hanne⁶,Heyman Mats⁷,Hultdin Magnus¹,Roos Göran¹,Forestier Erik¹,Degerman Sofie¹⁴

Affiliation:

1. Department of Medical Biosciences Umeå University Umeå Sweden

2. Department of Clinical Sciences and Pediatrics Umeå University Umeå Sweden

3. Department of Paediatrics and Adolescent Medicine University Hospital Rigshospitalet Copenhagen Denmark

4. Department of Paediatrics University Hospital of Trondheim Norway

5. Hospital for Children and Adolescents University of Helsinki Helsinki Finland

6. Department of Clinical Immunology University Hospital Rigshospitalet Copenhagen Denmark

7. Department of Woman and Child health Karolinska Institute Stockholm Sweden

Funder

Swedish Cancer Society

Swedish Research Council

Swedish Childhood Cancer Foundation

Medical Faculty of Umeå University

Danish Childhood Cancer Foundation

Lion's Cancer Research Foundation, Umeå

Umeå Paediatric Clinic Research Foundation

Magnus Bergvalls stiftelse

Uppsala-Umeå Comprehensive Cancer Consortium

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.25958

Reference39 articles.

1. Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

2. The molecular basis of T cell acute lymphoblastic leukemia

3. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL);Bene MC;Leukemia,1995

4. Epigenetics in Cancer

5. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia—associations with immunophenotype and cytogenetic subgroup

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length;Clinical Epigenetics;2024-05-21

2. Génomique fonctionnelle et innovations thérapeutiques dans les leucémies aiguës lymphoblastiques T;Hématologie;2024-01-01

3. The landscape of alterations affecting epigenetic regulators in T‐cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities;International Journal of Cancer;2023-12-28

4. Recent advances in understanding DNA methylation of prostate cancer;Frontiers in Oncology;2023-05-10

5. Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma;Cancers;2023-01-20